Mynaric AG Key Executives
This section highlights Mynaric AG's key executives, including their titles and compensation details.
Find Contacts at Mynaric AG
(Showing 0 of )
Mynaric AG Earnings
This section highlights Mynaric AG's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2023 | 2024-06-20 | $-2.70 | $-9.79 |
| Read Transcript | Q2 | 2023 | 2023-09-14 | N/A | N/A |
Mynaric AG engages in developing and manufacturing advanced laser communication technology for long-distance data transmission between moving objects for wireless terrestrial, airborne, and space applications in Germany and internationally. The company offers CONDOR, an optical inter-satellite link flight terminal for satellite-to-satellite communications in space; and HAWK, an airborne flight terminal for air-to-air and air-to-ground links of airborne vehicles. Its products provide connectivity solutions to link satellites, high-altitude platforms, unmanned aerial vehicles, aircraft, and the ground. The company was incorporated in 2009 and is headquartered in Gilching, Germany.
$0.26
Stock Price
$1.66M
Market Cap
500
Employees
Gilching, None
Location
Financial Statements
Access annual & quarterly financial statements for Mynaric AG, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Revenue | $5.39M | $4.42M | $2.35M | $679.00K | $114.00K |
| Cost of Revenue | $16.73M | $56.98M | $33.32M | $16.00M | $2.89M |
| Gross Profit | $-11.34M | $-52.55M | $-30.97M | $-15.32M | $-2.78M |
| Gross Profit Ratio | -210.40% | -1188.44% | -1315.00% | -2256.70% | -2437.72% |
| Research and Development Expenses | $- | $18.02M | $17.83M | $6.20M | $2.07M |
| General and Administrative Expenses | $49.70M | $50.03M | $27.34M | $19.69M | $8.18M |
| Selling and Marketing Expenses | $1.11M | $2.28M | $1.64M | $451.00K | $1.25M |
| Selling General and Administrative Expenses | $50.81M | $4.06M | $-6.24M | $-859.00K | $9.43M |
| Other Expenses | $17.01M | $- | $-240.00K | $- | $430.00K |
| Operating Expenses | $67.82M | $22.08M | $11.83M | $5.34M | $12.98M |
| Cost and Expenses | $84.55M | $79.06M | $45.15M | $21.35M | $15.87M |
| Interest Income | $333.00K | $2.54M | $2.15M | $18.00K | $73.00K |
| Interest Expense | $15.86M | $2.63M | $2.38M | $1.05M | $101.00K |
| Depreciation and Amortization | $7.14M | $6.46M | $4.52M | $1.84M | $1.18M |
| EBITDA | $-71.08M | $-68.18M | $-40.37M | $-17.93M | $-8.78M |
| EBITDA Ratio | -1318.66% | -1541.77% | -1625.52% | -2772.31% | -8490.35% |
| Operating Income | $-79.16M | $-74.64M | $-42.80M | $-20.67M | $-10.08M |
| Operating Income Ratio | -1468.70% | -1687.81% | -1817.37% | -3043.74% | -8840.35% |
| Total Other Income Expenses Net | $-14.92M | $-16.00K | $-1.32M | $-513.00K | $182.00K |
| Income Before Tax | $-94.08M | $-73.76M | $-43.69M | $-20.64M | $-9.90M |
| Income Before Tax Ratio | -1745.45% | -1668.05% | -1855.03% | -3040.06% | -8680.70% |
| Income Tax Expense | $-552.00K | $-24.00K | $1.79M | $-1.00K | $161.16K |
| Net Income | $-93.53M | $-73.78M | $-45.48M | $-20.64M | $-9.90M |
| Net Income Ratio | -1735.21% | -1668.52% | -1931.08% | -3040.06% | -8680.70% |
| EPS | $-3.87 | $-3.39 | $-2.68 | $-1.54 | $-0.85 |
| EPS Diluted | $-3.87 | $-3.39 | $-2.68 | $-1.54 | $-0.85 |
| Weighted Average Shares Outstanding | 24.17M | 21.74M | 17.00M | 13.40M | 11.62M |
| Weighted Average Shares Outstanding Diluted | 24.17M | 21.74M | 17.00M | 13.40M | 11.62M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | December 31, 2018 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 | June 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $910.00K | $4.43M | $4.40M | $25.00K | $1.01M | $1.35M | $653.54K | $25.46K | $3.63M | $207.02K | $334.29K | $2.99M | $2.10M | $782.96K | $67.91K | $441.11K |
| Cost of Revenue | $13.36M | $25.02M | $33.25M | $25.25M | $19.62M | $13.70M | $11.39M | $5.37M | $2.14M | $2.38M | $3.71M | $1.21M | $1.38M | $135.08K | $140.21K | $335.61K |
| Gross Profit | $-12.45M | $-20.60M | $-28.86M | $-25.23M | $-18.62M | $-12.35M | $-10.73M | $-5.35M | $1.49M | $-2.17M | $-3.37M | $1.78M | $720.50K | $647.88K | $-72.31K | $105.50K |
| Gross Profit Ratio | -1367.80% | -465.10% | -656.20% | -100916.00% | -1850.70% | -915.60% | -1642.51% | -21000.44% | 40.96% | -1050.36% | -1009.16% | 59.47% | 34.25% | 82.75% | -106.48% | 23.92% |
| Research and Development Expenses | $22.87M | $- | $19.38M | $- | $19.00M | $- | $6.36M | $- | $2.07M | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $- | $- | $- | $- | $21.73M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $-1.23M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $17.48M | $8.71M | $11.48M | $10.60M | $7.67M | $4.16M | $3.15M | $3.08M | $5.62M | $1.62M | $2.71M | $3.30M | $1.71M | $1.36M | $1.06M | $848.45K |
| Other Expenses | $-1.92M | $- | $1.49M | $884.00K | $164.00K | $271.00K | $57.00K | $186.00K | $- | $-670 | $172.22K | $- | $- | $- | $- | $- |
| Operating Expenses | $38.43M | $8.71M | $9.99M | $9.72M | $7.51M | $3.89M | $3.09M | $2.89M | $7.76M | $1.62M | $2.54M | $5.45M | $2.42M | $2.04M | $1.17M | $983.38K |
| Cost and Expenses | $51.78M | $33.74M | $43.24M | $34.97M | $27.13M | $17.59M | $14.48M | $8.26M | $9.90M | $4.00M | $6.25M | $6.66M | $3.80M | $2.18M | $1.31M | $1.32M |
| Interest Income | $333.00K | $3.67M | $2.12M | $360.00K | $2.14M | $7.00K | $1.10K | $16.90K | $81.77K | $8.77K | $2.11K | $2.13K | $3.65K | $25.74K | $5.99K | $1.24K |
| Interest Expense | $12.25M | $3.69M | $2.12M | $425.00K | $2.14M | $7.00K | $990.37K | $64.63K | $- | $- | $1 | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $1.35M | $3.29M | $4.93M | $3.06M | $2.60M | $1.92M | $1.13M | $883.56K | $-110.57K | $400.81K | $265.80K | $249.47K | $63.88K | $63.88K | $76.36K | $51.41K |
| EBITDA | $-44.04M | $-26.02M | $-33.91M | $-31.89M | $-26.14M | $-14.32M | $-12.69M | $-6.46M | $-6.45M | $-3.39M | $-3.90M | $-3.47M | $-1.63M | $-1.33M | $-881.55K | $-826.46K |
| EBITDA Ratio | -4839.34% | -587.51% | -771.18% | -127568.00% | -2338.17% | -1061.82% | -1942.27% | -28887.51% | -177.75% | -1638.15% | -1689.70% | -115.93% | -77.54% | -169.95% | -1298.17% | -187.36% |
| Operating Income | $-50.88M | $-29.31M | $-38.84M | $-34.95M | $-26.12M | $-16.24M | $-13.83M | $-8.24M | $-6.34M | $-3.79M | $-5.91M | $-3.72M | $-1.69M | $-1.39M | $-957.91K | $-877.87K |
| Operating Income Ratio | -5590.66% | -661.92% | -883.40% | -139788.00% | -2596.82% | -1203.85% | -2115.70% | -32358.03% | -174.70% | -1831.76% | -1769.21% | -124.26% | -80.57% | -178.11% | -1410.62% | -199.01% |
| Total Other Income Expenses Net | $-10.76M | $-3.13M | $-2.01M | $2.04M | $-1.49M | $163.00K | $477.97K | $-19.00K | $153.77K | $12.93K | $1.80M | $56.13K | $3.65K | $25.74K | $168.42K | $-136.16K |
| Income Before Tax | $-61.64M | $-32.44M | $-40.85M | $-32.91M | $-27.61M | $-16.08M | $-14.99M | $-7.75M | $-6.19M | $-3.78M | $-5.95M | $-3.66M | $-1.69M | $-1.37M | $-963.90K | $-879.11K |
| Income Before Tax Ratio | -6773.19% | -732.70% | -929.02% | -131648.00% | -2744.43% | -1191.77% | -2294.18% | -30447.39% | -170.47% | -1825.51% | -1778.81% | -122.39% | -80.40% | -174.83% | -1419.45% | -199.29% |
| Income Tax Expense | $552.00K | $- | $-24.00K | $- | $1.79M | $-1 | $-199.46K | $198.46K | $127.65K | $3.96K | $1.03K | $- | $- | $- | $248 | $248 |
| Net Income | $-61.08M | $-32.44M | $-40.87M | $-32.91M | $-29.40M | $-16.08M | $-14.79M | $-7.95M | $-6.06M | $-3.78M | $-5.95M | $-3.66M | $-1.69M | $-1.37M | $-963.65K | $-879.35K |
| Net Income Ratio | -6712.53% | -732.70% | -929.50% | -131648.00% | -2922.47% | -1191.77% | -2263.66% | -31226.92% | -166.95% | -1827.42% | -1779.12% | -122.39% | -80.40% | -174.83% | -1419.08% | -199.35% |
| EPS | $-2.45 | $-1.39 | $-1.83 | $-1.57 | $-1.69 | $-0.98 | $-0.90 | $-0.62 | $-0.52 | $-0.32 | $-0.54 | $-0.34 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS Diluted | $-2.45 | $-1.39 | $-1.83 | $-1.57 | $-1.69 | $-0.98 | $-0.90 | $-0.62 | $-0.52 | $-0.32 | $-0.54 | $-0.34 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Shares Outstanding | 24.95M | 23.39M | 22.41M | 20.97M | 17.38M | 16.34M | 16.37M | 12.86M | 11.59M | 11.92M | 11.09M | 10.82M | - | - | - | - |
| Weighted Average Shares Outstanding Diluted | 24.95M | 23.39M | 22.41M | 20.97M | 17.38M | 16.34M | 16.37M | 12.86M | 11.62M | 11.92M | 11.09M | 10.82M | - | - | - | - |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $23.96M | $10.24M | $48.14M | $43.20M | $8.91M |
| Short Term Investments | $- | $172.00K | $48.00K | $77.00K | $782.00K |
| Cash and Short Term Investments | $23.96M | $10.41M | $48.14M | $43.20M | $9.70M |
| Net Receivables | $300.00K | $1.10M | $- | $1.17M | $- |
| Inventory | $22.70M | $13.35M | $8.49M | $5.31M | $1.27M |
| Other Current Assets | $8.49M | $5.68M | $5.51M | $1.34M | $987.00K |
| Total Current Assets | $55.45M | $30.37M | $62.05M | $50.32M | $11.95M |
| Property Plant Equipment Net | $49.10M | $31.09M | $25.59M | $18.02M | $10.65M |
| Goodwill | $- | $- | $- | $- | $- |
| Intangible Assets | $263.00K | $18.06M | $19.97M | $17.88M | $85.00K |
| Goodwill and Intangible Assets | $263.00K | $18.06M | $19.97M | $17.88M | $85.00K |
| Long Term Investments | $- | $355.00K | $-1 | $- | $- |
| Tax Assets | $- | $3.58M | $3.67M | $4.96M | $- |
| Other Non-Current Assets | $14.27M | $449.00K | $411.00K | $359.00K | $-10.73M |
| Total Non-Current Assets | $63.64M | $53.53M | $49.65M | $41.22M | $10.73M |
| Other Assets | $- | $- | $1 | $- | $8.89M |
| Total Assets | $119.09M | $83.90M | $111.70M | $91.53M | $31.57M |
| Account Payables | $7.63M | $4.22M | $4.38M | $1.71M | $1.21M |
| Short Term Debt | $8.73M | $16.30M | $1.64M | $1.16M | $790.00K |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $205.00K | $307.00K | $1.20M | $-664.00K |
| Other Current Liabilities | $58.53M | $22.69M | $7.71M | $6.03M | $1.76M |
| Total Current Liabilities | $74.89M | $43.21M | $13.72M | $8.90M | $3.76M |
| Long Term Debt | $79.33M | $7.09M | $7.39M | $6.80M | $5.97M |
| Deferred Revenue Non-Current | $- | $-1 | $- | $-1 | $- |
| Deferred Tax Liabilities Non-Current | $- | $5.34M | $5.46M | $4.96M | $- |
| Other Non-Current Liabilities | $14.16M | $5.81M | $211.00K | $5.13M | $105.00K |
| Total Non-Current Liabilities | $93.49M | $12.90M | $13.06M | $11.93M | $6.11M |
| Other Liabilities | $- | $1 | $- | $1 | $-29.00K |
| Total Liabilities | $168.37M | $56.10M | $26.79M | $20.82M | $9.84M |
| Preferred Stock | $- | $- | $- | $- | $53.00K |
| Common Stock | $6.23M | $5.67M | $5.24M | $4.00M | $2.90M |
| Retained Earnings | $-260.08M | $-166.55M | $-92.77M | $-47.29M | $-27.52M |
| Accumulated Other Comprehensive Income Loss | $531.00K | $-595.00K | $-184.00K | $5.81M | $-53.00K |
| Other Total Stockholders Equity | $204.03M | $- | $172.62M | $1 | $-872.00K |
| Total Stockholders Equity | $-49.29M | $27.79M | $84.91M | $70.71M | $21.74M |
| Total Equity | $-49.29M | $27.79M | $84.91M | $70.71M | $21.74M |
| Total Liabilities and Stockholders Equity | $119.09M | $83.90M | $111.70M | $91.53M | $34.54M |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $119.09M | $83.90M | $111.70M | $91.53M | $34.54M |
| Total Investments | $- | $527.00K | $48.00K | $77.00K | $782.00K |
| Total Debt | $88.06M | $22.05M | $9.03M | $7.96M | $6.74M |
| Net Debt | $64.10M | $11.81M | $-39.12M | $-35.24M | $-2.17M |
Balance Sheet Charts
| Breakdown | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | December 31, 2018 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $23.96M | $47.25M | $10.24M | $25.51M | $48.14M | $18.44M | $43.20M | $6.66M | $8.91M | $18.51M | $12.92M | $17.32M | $1.58M | $347.77K | $227.01K |
| Short Term Investments | $- | $- | $172.00K | $8.68M | $48.00K | $3.75M | $77.00K | $50.00K | $782.00K | $- | $903.85K | $- | $- | $- | $- |
| Cash and Short Term Investments | $23.96M | $47.25M | $10.41M | $25.51M | $48.14M | $18.44M | $43.20M | $6.66M | $9.70M | $18.51M | $13.83M | $17.32M | $1.58M | $347.77K | $227.01K |
| Net Receivables | $300.00K | $- | $1.10M | $- | $- | $- | $1.17M | $238.71K | $- | $302.92K | $317.10K | $- | $55.94K | $938.39K | $501.74K |
| Inventory | $22.70M | $17.93M | $13.35M | $13.39M | $8.49M | $9.07M | $5.23M | $6.15M | $1.27M | $2.91M | $2.00M | $-8.44M | $420.71K | $408.63K | $417.12K |
| Other Current Assets | $8.49M | $8.58M | $5.68M | $- | $5.51M | $- | $1.34M | $627.87K | $987.00K | $448.43K | $365.00K | $8.67M | $465.00K | $- | $- |
| Total Current Assets | $55.45M | $73.75M | $30.37M | $47.58M | $62.05M | $31.26M | $49.92M | $13.91M | $11.95M | $22.18M | $16.51M | $25.98M | $2.52M | $1.69M | $1.15M |
| Property Plant Equipment Net | $49.10M | $32.13M | $31.09M | $29.38M | $25.59M | $20.58M | $18.02M | $11.53M | $10.65M | $2.02M | $2.45M | $150.96K | $1.79M | $699.11K | $613.74K |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $263.00K | $17.35M | $18.06M | $20.18M | $19.97M | $19.84M | $17.88M | $14.86M | $85.00K | $7.19M | $4.23M | $161.56K | $34.82K | $164.03K | $162.88K |
| Goodwill and Intangible Assets | $263.00K | $17.35M | $18.06M | $20.18M | $19.97M | $19.84M | $17.88M | $14.86M | $85.00K | $7.19M | $4.23M | $161.56K | $34.82K | $164.03K | $162.88K |
| Long Term Investments | $- | $355.00K | $355.00K | $425.00K | $-1 | $401.00K | $- | $- | $- | $- | $1.57M | $4.96M | $- | $11.57K | $11.57K |
| Tax Assets | $- | $1 | $3.58M | $-425.00K | $3.67M | $-401.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $14.27M | $433.00K | $449.00K | $425.00K | $411.00K | $401.00K | $760.00K | $651.54K | $-10.73M | $-9.21M | $-8.25M | $-5.27M | $35.11K | $26.14K | $8.76K |
| Total Non-Current Assets | $63.64M | $50.27M | $53.53M | $49.98M | $49.65M | $40.82M | $36.66M | $27.04M | $10.73M | $9.21M | $8.25M | $5.27M | $1.86M | $900.84K | $796.95K |
| Other Assets | $- | $- | $- | $1 | $1 | $- | $- | $- | $8.89M | $921.79K | $- | $178.07K | $- | $- | $- |
| Total Assets | $119.09M | $124.03M | $83.90M | $97.57M | $111.70M | $72.09M | $86.58M | $40.95M | $31.57M | $32.31M | $24.76M | $31.44M | $4.38M | $2.60M | $1.94M |
| Account Payables | $7.63M | $9.33M | $4.22M | $10.20M | $4.38M | $6.51M | $1.71M | $2.00M | $1.21M | $313.94K | $1.27M | $112.34K | $- | $- | $- |
| Short Term Debt | $8.73M | $4.91M | $16.30M | $11.94M | $1.64M | $1.28M | $1.16M | $671.01K | $790.00K | $- | $- | $- | $- | $- | $- |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $128.00K | $103.00K | $- | $- | $- | $- |
| Deferred Revenue | $- | $31.18M | $205.00K | $613.00K | $307.00K | $1.17M | $299.00K | $115.22K | $-664.09K | $- | $- | $- | $- | $- | $- |
| Other Current Liabilities | $58.53M | $33.58M | $22.69M | $12.55M | $7.71M | $2.67M | $6.03M | $2.71M | $1.76M | $1.36M | $1.33M | $548.23K | $2.41M | $- | $1.32M |
| Total Current Liabilities | $74.89M | $47.82M | $43.21M | $34.68M | $13.72M | $10.47M | $8.89M | $5.50M | $3.76M | $1.80M | $2.70M | $660.57K | $2.41M | $- | $1.32M |
| Long Term Debt | $79.33M | $6.37M | $7.09M | $6.88M | $7.39M | $6.65M | $6.80M | $5.74M | $5.97M | $- | $- | $- | $- | $- | $- |
| Deferred Revenue Non-Current | $- | $6.37M | $-1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $1.77M | $5.34M | $1.79M | $5.46M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $14.16M | $61.24M | $5.81M | $2.01M | $5.67M | $194.00K | $179.00K | $25.40K | $105.00K | $- | $1.31M | $44.03K | $- | $- | $- |
| Total Non-Current Liabilities | $93.49M | $67.61M | $12.90M | $8.89M | $13.06M | $6.85M | $6.98M | $5.77M | $6.11M | $1.31M | $1.31M | $408.03K | $- | $- | $- |
| Other Liabilities | $- | $- | $1 | $- | $- | $1 | $1 | $- | $-29.10K | $-1.31M | $-1.28M | $-364.00K | $- | $- | $1 |
| Total Liabilities | $168.37M | $115.42M | $56.10M | $43.57M | $26.79M | $17.32M | $15.87M | $11.26M | $9.84M | $1.80M | $2.73M | $704.60K | $2.41M | $- | $1.32M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $52.63K | $32.45K | $- | $- | $- | $1 | $- |
| Common Stock | $6.23M | $6.23M | $5.67M | $5.24M | $5.24M | $4.09M | $4.09M | $3.19M | $2.90M | $2.90M | $2.70M | $2.70M | $32.45K | $32.45K | $28.95K |
| Retained Earnings | $-260.08M | $-198.99M | $-166.55M | $-125.68M | $-92.77M | $-63.37M | $-46.11M | $-32.13M | $-27.52M | $-20.50M | $-16.35M | $-3.67M | $-5.94M | $-4.25M | $-2.88M |
| Accumulated Other Comprehensive Income Loss | $531.00K | $-113.00K | $-595.00K | $-1.16M | $-184.00K | $176.00K | $314.00K | $-18.57K | $-52.63K | $-32.45K | $37.33M | $31.69M | $7.56M | $5.54M | $3.11M |
| Other Total Stockholders Equity | $204.03M | $- | $- | $-1.00K | $172.62M | $1 | $108.19M | $58.64M | $-872.00K | $48.14M | $- | $31.69M | $1 | $-1.93K | $-1 |
| Total Stockholders Equity | $-49.29M | $8.60M | $27.79M | $54.00M | $84.91M | $54.77M | $70.71M | $29.69M | $21.74M | $30.51M | $22.04M | $30.73M | $1.66M | $1.32M | $261.72K |
| Total Equity | $-49.29M | $8.60M | $27.79M | $54.00M | $84.91M | $54.77M | $70.71M | $29.69M | $21.74M | $30.51M | $22.04M | $30.73M | $1.66M | $1.32M | $261.72K |
| Total Liabilities and Stockholders Equity | $119.09M | $124.03M | $83.90M | $97.57M | $111.70M | $72.09M | $86.58M | $40.95M | $34.54M | $32.31M | $26.04M | $31.44M | $4.07M | $1.32M | $1.94M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $119.09M | $124.03M | $83.90M | $97.57M | $111.70M | $72.09M | $86.58M | $40.95M | $34.54M | $32.31M | $26.04M | $31.44M | $4.07M | $1.32M | $1.94M |
| Total Investments | $- | $355.00K | $527.00K | $9.11M | $48.00K | $401.00K | $77.00K | $50.00K | $782.00K | $- | $2.47M | $4.96M | $- | $11.57K | $11.57K |
| Total Debt | $88.06M | $70.31M | $22.05M | $18.82M | $9.03M | $7.93M | $7.96M | $6.41M | $6.74M | $- | $- | $- | $- | $- | $- |
| Net Debt | $64.10M | $23.06M | $11.81M | $-6.69M | $-39.12M | $-10.51M | $-35.24M | $-243.77K | $-2.17M | $-18.51M | $-12.92M | $-17.32M | $-1.58M | $-347.77K | $-227.01K |
Annual Cash Flow
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Net Income | $-93.53M | $-73.78M | $-45.48M | $-20.64M | $-9.90M |
| Depreciation and Amortization | $7.14M | $6.46M | $4.52M | $1.84M | $889.00K |
| Deferred Income Tax | $-552.00K | $-24.00K | $1.79M | $-1.00K | $-269.00K |
| Stock Based Compensation | $3.97M | $6.13M | $1.94M | $1.12M | $105.50K |
| Change in Working Capital | $33.95M | $9.35M | $-3.54M | $178.00K | $-877.00K |
| Accounts Receivables | $732.00K | $-1.12M | $572.00K | $-589.00K | $105.00K |
| Inventory | $-9.38M | $-4.96M | $-3.17M | $-2.90M | $-982.00K |
| Accounts Payables | $5.91M | $2.23M | $2.32M | $2.42M | $-31.56K |
| Other Working Capital | $36.69M | $13.19M | $-3.27M | $1.24M | $31.56K |
| Other Non Cash Items | $20.03M | $1.41M | $-1.04M | $90.00K | $688.00K |
| Net Cash Provided by Operating Activities | $-28.98M | $-50.46M | $-41.81M | $-17.41M | $-8.32M |
| Investments in Property Plant and Equipment | $-4.85M | $-11.30M | $-10.96M | $-15.01M | $-1.89M |
| Acquisitions Net | $- | $-400.00K | $- | $- | $- |
| Purchases of Investments | $- | $-400.00K | $- | $- | $- |
| Sales Maturities of Investments | $- | $1.92M | $- | $- | $1.56M |
| Other Investing Activities | $263.00K | $-1.52M | $-3.35M | $-8.20M | $-6.83M |
| Net Cash Used for Investing Activities | $-4.59M | $-11.70M | $-10.96M | $-15.01M | $-7.16M |
| Debt Repayment | $52.27M | $11.72M | $-1.06M | $4.33M | $-439.00K |
| Common Stock Issued | $12.77M | $11.20M | $66.54M | $65.14M | $10.42M |
| Common Stock Repurchased | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $-17.96M | $10.25M | $-10.68M | $-3.21M | $1.48M |
| Net Cash Used Provided by Financing Activities | $47.09M | $22.21M | $57.18M | $66.81M | $11.46M |
| Effect of Forex Changes on Cash | $205.00K | $2.04M | $527.00K | $-111.00K | $11.00K |
| Net Change in Cash | $13.72M | $-37.91M | $4.95M | $34.28M | $-4.01M |
| Cash at End of Period | $23.96M | $10.24M | $48.14M | $43.20M | $8.91M |
| Cash at Beginning of Period | $10.24M | $48.14M | $43.20M | $8.91M | $12.92M |
| Operating Cash Flow | $-28.98M | $-50.46M | $-41.81M | $-17.41M | $-8.32M |
| Capital Expenditure | $-4.92M | $-11.30M | $-10.96M | $-15.01M | $-1.89M |
| Free Cash Flow | $-33.91M | $-61.76M | $-52.77M | $-32.42M | $-10.21M |
Cash Flow Charts
| Breakdown | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | December 31, 2018 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 | June 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-61.08M | $-32.44M | $-40.87M | $-32.91M | $-29.40M | $-16.08M | $-14.79M | $-7.95M | $-6.06M | $-3.78M | $-4.11M | $-3.66M | $-1.69M | $-1.37M | $-963.65K | $-879.35K |
| Depreciation and Amortization | $3.85M | $3.29M | $4.93M | $3.06M | $2.60M | $1.92M | $1.13M | $883.56K | $379.43K | $400.81K | $265.80K | $- | $- | $- | $- | $- |
| Deferred Income Tax | $- | $-13.70M | $-14.38M | $-11.57M | $-5.33M | $-5.92M | $-2.47M | $-2.69M | $-811.96K | $542.96K | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $2.55M | $1.42M | $3.16M | $2.97M | $1.66M | $278.00K | $199.00K | $926.00K | $1.12M | $27.87K | $31.69K | $- | $- | $- | $- | $- |
| Change in Working Capital | $-4.42M | $7.57M | $6.25M | $3.10M | $836.00K | $-4.38M | $3.48M | $-1.93M | $721.25K | $-1.53M | $- | $- | $- | $- | $- | $- |
| Accounts Receivables | $-353.00K | $1.08M | $-1.12M | $- | $10.00K | $562.00K | $-589.00K | $- | $675.82K | $-570.82K | $- | $- | $- | $- | $- | $- |
| Inventory | $-4.79M | $-4.58M | $47.00K | $-5.00M | $672.00K | $-3.84M | $56.00K | $-2.95M | $-982.00K | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $8.09M | $-2.19M | $-279.00K | $2.51M | $856.00K | $1.46M | $-2.02M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $-7.37M | $13.25M | $7.60M | $5.59M | $-702.00K | $-2.56M | $6.03M | $-1.93M | $1.03M | $-1.53M | $- | $- | $- | $- | $- | $- |
| Other Non Cash Items | $45.75M | $12.87M | $16.80M | $9.02M | $6.12M | $5.88M | $1.63M | $2.89M | $185.85K | $651.66K | $4.08M | $3.66M | $1.69M | $1.37M | $963.65K | $879.35K |
| Net Cash Provided by Operating Activities | $-13.36M | $-20.99M | $-24.11M | $-26.34M | $-23.50M | $-18.30M | $-10.82M | $-7.87M | $-3.65M | $-5.06M | $297.49K | $- | $- | $- | $- | $- |
| Investments in Property Plant and Equipment | $-3.37M | $-1.53M | $-3.94M | $-7.36M | $-4.99M | $-5.97M | $-7.22M | $-6.50M | $580.37K | $-2.77M | $- | $- | $- | $- | $- | $- |
| Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $3.50K | $-3.50K | $- | $- | $- | $- | $- | $- |
| Purchases of Investments | $- | $- | $-400.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $777.86K | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $313.00K | $-50.00K | $-551.00K | $-969.00K | $-841.00K | $-2.50M | $-1.50K | $1.50K | $-6.05M | $773.28K | $- | $- | $- | $- | $- | $- |
| Net Cash Used for Investing Activities | $-3.06M | $-1.53M | $-4.34M | $-7.36M | $-4.99M | $-5.97M | $-8.00M | $-5.72M | $-5.47M | $-2.77M | $- | $- | $- | $- | $- | $- |
| Debt Repayment | $- | $53.67M | $- | $9.27M | $- | $-504.00K | $- | $-335.00K | $- | $-108.32K | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $-1.00K | $11.35M | $10.94M | $- | $58.24M | $- | $50.12M | $11.63M | $- | $11.00M | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $-130.99K | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-6.77M | $5.55M | $12.94M | $-563.00K | $55.39M | $-84.00K | $55.51M | $11.63M | $1.16M | $11.25M | $- | $- | $- | $- | $- | $- |
| Net Cash Used Provided by Financing Activities | $-6.77M | $59.22M | $12.94M | $9.27M | $57.69M | $-504.00K | $55.51M | $11.30M | $1.02M | $11.14M | $- | $- | $- | $- | $- | $- |
| Effect of Forex Changes on Cash | $-108.00K | $313.00K | $248.00K | $1.79M | $501.00K | $26.00K | $-107.00K | $-4.00K | $52.90K | $-41.90K | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-23.29M | $37.01M | $-15.27M | $-22.64M | $29.70M | $-24.75M | $36.54M | $-11.86M | $-8.04M | $3.28M | $297.49K | $- | $- | $- | $- | $- |
| Cash at End of Period | $23.96M | $47.25M | $10.24M | $25.51M | $48.14M | $18.44M | $43.20M | $6.66M | $8.93M | $18.51M | $15.24M | $- | $- | $- | $- | $- |
| Cash at Beginning of Period | $47.25M | $10.24M | $25.51M | $48.14M | $18.44M | $43.20M | $6.66M | $18.51M | $16.98M | $15.24M | $14.94M | $- | $- | $- | $- | $- |
| Operating Cash Flow | $-13.36M | $-20.99M | $-24.11M | $-26.34M | $-23.50M | $-18.30M | $-10.82M | $-7.87M | $-3.65M | $-5.06M | $297.49K | $- | $- | $- | $- | $- |
| Capital Expenditure | $-3.37M | $-1.53M | $-3.94M | $-7.36M | $-4.99M | $-5.97M | $-7.22M | $-6.50M | $580.37K | $-2.77M | $- | $- | $- | $- | $- | $- |
| Free Cash Flow | $-16.73M | $-22.52M | $-28.06M | $-33.70M | $-28.49M | $-24.28M | $-18.04M | $-14.37M | $-3.07M | $-7.84M | $297.49K | $- | $- | $- | $- | $- |
Mynaric AG Dividends
Explore Mynaric AG's dividend history, including dividend yield, payout ratio, and historical payments.
Mynaric AG News
Read the latest news about Mynaric AG, including recent articles, headlines, and updates.
Mynaric AG: Resignation of Bulent Altan as Chairman and Member of Supervisory Board
MUNICH, DE / ACCESS Newswire / March 28, 2025 / Mynaric AG (FRA:M0YN)(OTC PINK:MYNAY) (the "Company") announces that Bulent Altan today has tendered his resignation as Chairman and Member of the Supervisory Board of the Company for personal reasons effective April 1, 2025. Bulent Altan was elected Chairman of the Supervisory Board of the Company following his election as member of the Supervisory Board by the General Assembly in August 2023.
Rocket Lab Announces Intention to Acquire Mynaric, Leading Laser Communications Provider, in Latest Strategic Step Toward Becoming an End-to-End Space Company
LONG BEACH, Calif.--(BUSINESS WIRE)---- $RKLB--Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or the “Company”), a global leader in launch services and space systems, today announced it has entered into a non-binding term sheet with certain lenders (together, the “Lenders”) to acquire, subject to receipt of certain governmental approvals including those described herein, a controlling equity position in Mynaric AG (“Mynaric”). Mynaric is a leading provider of laser optical communications terminals for.
Mynaric Updates on Operational Continuity and Ongoing Production and Deliveries
Mynaric is continuing to ramp up and increase deliveries of its flagship CONDOR Mk3 StaRUG proceedings intended to place company on secure financial footing moving forward MUNICH , March 10, 2025 /PRNewswire/ -- Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective, and scalable laser communications products, today confirms that it is continuing to ramp up production and customer deliveries of the CONDOR Mk3 optical communications terminal and updates on the background to the company's StaRUG proceedings. "We are continuing to deliver on our promise to the industry to provide scalable products that meet evolving program requirements, and drive innovation in areas such as multi-orbit constellations.
Mynaric Announces Receipt of Delisting Notice from Nasdaq
MUNICH, GERMANY / ACCESS Newswire / February 13, 2025 / Mynaric (NASDAQ:MYNA)(FRA:M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, announces that it received a delisting notification dated February 10, 2025 (the "Delisting Notice") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq"). As previously disclosed, on February 7, 2025, Mynaric's management board, with the approval of its supervisory board, resolved on a financial restructuring by proceedings under the German Corporate Stabilization and Restructuring Act (Gesetz über den Stabilisierungs- und Restrukturierungsrahmen für Unternehmen) and notified the competent Munich Local Court - Restructuring Court - of such restructuring project (the "StaRUG Proceeding").
Mynaric Secures Another USD 28 Million Bridge Loan, Extends Three Outstanding Bridge Loans, Agrees to USD 25 Million Restructuring Loan and Resolves on Reorganization Under StaRUG
MUNICH, DE / ACCESS Newswire / February 7, 2025 / Mynaric AG (NASDAQ:MYNA) (ISIN: US62857X1019) (FRA:M0YN) (ISIN: DE000A31C305) (the "Company") announces the grant of a fourth bridge loan, the extension of the maturity date of its three outstanding bridge loans, agrees to a new restructuring loan and resolves on a financial restructuring by proceedings under the German Corporate Stabilization and Restructuring Act (Gesetz über den Stabilisierungs- und Restrukturierungsrahmen für Unternehmen ("StaRUG"). Bridge Loans The Company today entered into an amendment to its existing loan agreement with its U.S.-based lenders CO FINANCE II LVS I LLC and OC III LVS LIII LP ("U.S. Lenders"), which are funds affiliated with the U.S.-based global investment management firm Pacific Investment Management Company LLC ("PIMCO"), pursuant to which the U.S. Lenders agreed to provide a fourth bridge loan in the amount of USD 28 million.
Mynaric Extends Maturity of Three Existing Bridge Loans Until February 7, 2025 and Expects Additional Bridge Loan, Restructuring Loan and Application for StaRUG Proceedings
MUNICH, DE / ACCESS Newswire / January 31, 2025 / Mynaric AG (NASDAQ:MYNA)(ISIN: US62857X1019)(FRA:M0YN)(ISIN: DE000A31C305) (the "Company") announces the extension of the maturity of its three bridge loans and the expectation to agree on a fourth bridge loan, a separate restructuring loan and an application for the initiation of a financial reorganization under the German Corporate Stabilization and Restructuring Act (Gesetz über den Stabilisierungs- und Restrukturierungsrahmen für Unternehmen ("StaRUG"). New maturity date of bridge loans The Company today entered into an amendment to its existing loan agreement with its U.S.-based lenders, which are funds affiliated with a U.S.-based global investment management firm (the "Lenders"), pursuant to which the Lenders have agreed to extend the maturity date of the three existing bridge loans in the aggregate amount of USD 21.5 million from January 31, 2025 to February 7, 2025.
Mynaric Announces Receipt of Deficiency Letter from Nasdaq
MUNICH, DE / ACCESS Newswire / January 29, 2025 / Mynaric (NASDAQ:MYNA)(FRA:M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, announces that it received a notification letter dated January 23, 2025 (the "Deficiency Letter") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq") notifying that Mynaric is no longer in compliance with the Nasdaq continued listing criteria, including the Nasdaq Listing Rule 5450(a)(1) due to its failure to meet the minimum closing bid price per share of Mynaric's American Depositary Shares representing its ordinary shares (the "ADS") of $1.00 for a period of 30 consecutive business days (the "Minimum Bid Price Requirement"). The Deficiency Letter has no immediate effect on the listing of Mynaric's ADS, which continue to trade under the symbol "MYNA.
Mynaric Announces Receipt of Deficiency Letters from Nasdaq
MUNICH, DE / ACCESSWIRE / January 15, 2025 / Mynaric (NASDAQ:MYNA)(FRA:M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announced that it received a notification letter dated January 9, 2025 (the "Deficiency Letter I") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq") notifying that Mynaric is no longer in compliance with the Nasdaq continued listing criteria, including the Nasdaq Listing Rule 5250(c)(2) due to its failure to file an interim balance sheet and income statement as of the end of its second quarter on Form 6-K no later than six months following the end of the Mynaric's second quarter (the "Interim Reporting Requirement"). Furthermore, Mynaric today announced that it received a notification letter dated January 13, 2025 (the "Deficiency Letter II") from Nasdaq notifying that Mynaric is no longer in compliance with Listing Rule 5620(a) due to its failure to hold an annual meeting of shareholders within twelve months of the end of the Mynaric's fiscal year (the "Annual Meeting Requirement").
Mynaric Updates Guidance on 2024 Key Performance Indicators, Lowering Revenue and Optical Communications Terminal Backlog Guidance
MUNICH, DE / ACCESSWIRE / January 3, 2025 / Mynaric AG (NASDAQ:MYNA; ISIN: US62857X1019)(FRA:M0YN; ISIN: DE000A31C305) (the "Company") updates its full-year 2024 guidance published on August 20, 2024, for two of its key financial performance metrics. IFRS-15 revenue: the Company now anticipates full-year 2024 IFRS-15 revenue of EUR 14.1 million compared to previous guidance of a range estimating between EUR 16.0 million to EUR 24.0 million.
MYNA DEADLINE TODAY: MYNA Investors Have Opportunity to Lead Mynaric AG Securities Fraud Lawsuit
NEW YORK , Dec. 30, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Mynaric AG (NASDAQ: MYNA) securities between June 20, 2024 and October 7, 2024, both dates inclusive (the "Class Period"), of the important December 30, 2024 lead plaintiff deadline. So what: If you purchased Mynaric securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
MYNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Mynaric AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA) and certain of its officers.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mynaric AG of Class Action Lawsuit and Upcoming Deadlines - MYNA
NEW YORK, NY / ACCESSWIRE / December 30, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA) and certain officers. The class action, filed in the United States District Court for the Eastern District Of New York, and docketed under 24-cv-07602 is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Mynaric securities between June 20, 2024 and October 7, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
FINAL REMINDER MYNA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Mynaric AG Investors to Participate in the Class Action Lawsuit
NEW YORK, NY / ACCESSWIRE / December 30, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Mynaric securities between June 20, 2024, and October 7, 2024, inclusive (the "Class Period").
MYNARIC DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Mynaric AG Investors to Secure Counsel Before Important December 30 Deadline in Securities Class Action – MYNA
NEW YORK, Dec. 29, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Mynaric AG (NASDAQ: MYNA) between June 20, 2024 and October 7, 2024, both dates inclusive (the “Class Period”), of the important December 30, 2024 lead plaintiff deadline.
DEADLINE TOMORROW: The Schall Law Firm Invites Shareholders To Reach Out About A Securities Fraud Case Against Mynaric AG
LOS ANGELES, CA / ACCESSWIRE / December 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 20, 2024 and October 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 30, 2024.
FINAL MYNA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Mynaric AG Investors to Join the Class Action Lawsuit
NEW YORK, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Mynaric securities between June 20, 2024, and October 7, 2024, inclusive (the "Class Period").
Mynaric AG Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 20, 2024 and October 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 30, 2024.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mynaric AG (MYNA)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Mynaric AG (“Mynaric” or the “Company”) (NASDAQ: MYNA) securities between June 20, 2024 and October 7, 2024, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On August 20, 2024, Mynaric disclosed that it “now expect[ed] full-.
The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Case Against Mynaric AG
LOS ANGELES, CA / ACCESSWIRE / December 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 20, 2024 and October 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 30, 2024.
MYNA Shareholders Have Opportunity to Lead Mynaric AG Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
NEW YORK, NY / ACCESSWIRE / December 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Mynaric securities between June 20, 2024, and October 7, 2024, inclusive (the "Class Period").
MYNARIC ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Mynaric AG and Encourages Investors to Contact the Firm
NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Mynaric AG (“Mynaric” or the “Company”) (NASDAQ:MYNA) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Mynaric securities between June 20, 2024 and October 7, 2024, both dates inclusive (the “Class Period”). Investors have until December 30, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
MYNARIC DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mynaric AG Investors to Secure Counsel Before Important December 30 Deadline in Securities Class Action – MYNA
NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Mynaric AG (NASDAQ: MYNA) between June 20, 2024 and October 7, 2024, both dates inclusive (the “Class Period”), of the important December 30, 2024 lead plaintiff deadline.
MYNA Investors Have Opportunity to Lead Mynaric AG Securities Fraud Lawsuit
LOS ANGELES , Dec. 26, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Mynaric AG ("Mynaric" or the "Company") (NASDAQ: MYNA). Class Period: June 20, 2024 – October 7, 2024 Lead Plaintiff Deadline: December 30, 2024 If you wish to serve as lead plaintiff of the Mynaric lawsuit, you can submit your contact information at www.glancylaw.com/cases/Mynaric-AG/.
Mynaric AG Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 20, 2024 and October 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 30, 2024.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for MYNA.